Лечение и препараты

FDA Approves Pembrolizumab in Metastatic TMB-H Solid Tumors

Казахстан обсудил с онкоцентром США обеспечение детей препаратами от рака

Казахстан обсудил с онкоцентром США обеспечение детей препаратами от рака Kursiv Media

Uncovering Hidden Drivers of Chemotherapy Resistance in Ovarian Cancer - One Biosciences

Uncovering Hidden Drivers of Chemotherapy Resistance in Ovarian Cancer - One Biosciences Oncodaily

В России создали новый способ терапии самого трудноизлечимого рака легкого

В России создали новый способ терапии самого трудноизлечимого рака легкого Здоровье Mail

FIRST PATIENT SITE OPENS: Burjeel Cancer Institute at Burjeel Medical City Launches World’s First Clinical Site for BioSapien’s MediChip™ Chemotherapy Platform

FIRST PATIENT SITE OPENS: Burjeel Cancer Institute at Burjeel Medical City Launches World’s First Clinical Site for BioSapien’s MediChip™ Chemotherapy Platform markets.businessinsider.com

Ученые нашли уязвимость агрессивного рака костей и испытали комбинацию препаратов

Ученые нашли уязвимость агрессивного рака костей и испытали комбинацию препаратов Naked Science

Ученые нашли уязвимость агрессивного рака костей и испытали комбинацию препаратов

Ученые нашли уязвимость агрессивного рака костей и испытали комбинацию препаратов Naked Science

Can better gut health help patients with ovarian cancer tolerate chemotherapy?

Can better gut health help patients with ovarian cancer tolerate chemotherapy? EurekAlert!

Can better gut health help patients with ovarian cancer tolerate chemotherapy? | Newswise

Can better gut health help patients with ovarian cancer tolerate chemotherapy? | Newswise Newswise

Arcus Presents New Data from ARC-20 that Demonstrate the Opportunity for Casdatifan to Become a Foundational Treatment Across All Lines of Therapy in Kidney Cancer

Arcus Presents New Data from ARC-20 that Demonstrate the Opportunity for Casdatifan to Become a Foundational Treatment Across All Lines of Therapy in Kidney Cancer BioSpace

Arcus Presents New Data from ARC-20 that Demonstrate the Opportunity for Casdatifan to Become a Foundational Treatment Across All Lines of Therapy in Kidney Cancer

Arcus Presents New Data from ARC-20 that Demonstrate the Opportunity for Casdatifan to Become a Foundational Treatment Across All Lines of Therapy in Kidney Cancer Morningstar

Arcus Presents New Data from ARC-20 that Demonstrate the Opportunity for Casdatifan to Become a Foundational Treatment Across All Lines of Therapy in Kidney Cancer

Arcus Presents New Data from ARC-20 that Demonstrate the Opportunity for Casdatifan to Become a Foundational Treatment Across All Lines of Therapy in Kidney Cancer Business Wire

Свет против рака: фотодинамическая терапия показала до 99% эффективности in vitro

Свет против рака: фотодинамическая терапия показала до 99% эффективности in vitro 9 Канал Израиль

Израиль обнаружил механизм, позволяющий раковым клеткам выживать после химиотерапии.

Израиль обнаружил механизм, позволяющий раковым клеткам выживать после химиотерапии. Vietnam.vn

A rapid clinical care program increased cancer care access for vulnerable patients

The rapid-access cancer care program Same Day/Next Day (SDND) served a higher proportion of patients with high socioeconomic risk for poor outcomes than the traditional health care path, and more socially vulnerable patients initiated therapy, according to results presented at the 19th AACR Conference on The Science…